Can You Take Wegovy With Gallstones?

What the trial data actually showed about gallbladder events

The STEP 1 trial (the pivotal 68-week study of semaglutide 2.4mg published in the New England Journal of Medicine) reported gallbladder-related adverse events more frequently in the semaglutide group than in the placebo group. Gallstones (cholelithiasis) and gallbladder inflammation (acute cholecystitis) were among those events. This wasn't a fringe signal picked up only after approval: it was visible in the controlled trial data before the medicine reached any pharmacy shelf.

The mechanism isn't fully resolved, but two things are likely in play. Semaglutide slows gastric emptying and alters how the gut signals bile release, which may allow bile to become more concentrated, a condition that promotes stone formation. Separately, meaningful weight loss itself (by any route) is a well-established trigger for gallstones, because fat mobilisation changes cholesterol secretion into bile. If you want a closer look at how Wegovy contributes to gall stones specifically, that page goes into the biliary mechanics in more detail.

The NHS medicines page for semaglutide lists gallbladder problems as a known side effect requiring medical attention. That's the plain-language version of what the SmPC sets out in more technical terms. Neither source says everyone will be affected (the absolute rates in trials were low) but the signal is real enough that it sits in the product information of every Wegovy pack.

How existing gallstones shift the prescriber's calculation

If you already have gallstones, you're not starting from a neutral baseline. You have a biliary system that has already shown it can form stones; adding a medicine associated with reduced gallbladder motility is a combination a prescriber will think through carefully. The considerations include whether your gallstones are currently causing symptoms, whether you've had any episodes of biliary colic or cholecystitis in the past, and whether you're under a surgical team's care for them.

Asymptomatic gallstones (stones found incidentally on a scan, causing no pain or episodes) sit in a different clinical category from stones that have already caused problems. A prescriber may be more comfortable proceeding in the former case with appropriate monitoring and advice. Symptomatic or complicated gallstone disease is a more cautious area. There's no blanket rule that applies to every person, which is exactly why the consultation process matters.

If you're exploring the broader picture of how Wegovy affects gallbladder health, that page covers the full mechanism and monitoring approach in more detail. For anyone weighing treatment costs alongside these clinical factors, our Wegovy pricing page explains what a private prescription typically includes.

Symptoms that need urgent attention, and a practical check

This is the part worth reading twice. Gallbladder problems don't always announce themselves gradually. Acute cholecystitis or a stone obstructing the bile duct can escalate quickly. The symptoms to take seriously are: severe or persistent pain in the upper right or upper central abdomen, pain that radiates to the right shoulder or through to the back, fever with abdominal pain, and yellowing of the skin or whites of the eyes (jaundice).

A quick checking habit worth building: any time you experience abdominal pain that lasts more than an hour and doesn't ease, note its location and whether it's spreading. That 60-second observation (where does it hurt, does it move, how long has it been there) is exactly what a clinician will ask you first. Catching that pattern early can make a real difference to how fast appropriate care starts.

The MHRA's Yellow Card scheme allows patients to report suspected side effects from any medicine, including gallbladder symptoms arising during semaglutide treatment. Reporting helps build the post-market evidence base that regulators rely on. If in doubt about any symptom, contact your prescriber or call 111 rather than waiting.

You can read more about what else to be aware of before and during treatment on our page covering interactions and precautions with semaglutide, or explore the full clinical profile of semaglutide as a medicine.

When to raise this with a prescriber, and what to tell them

Any history of gallstones, gallbladder surgery, biliary colic or cholecystitis belongs in your consultation. That includes stones found years ago on a scan even if they've never caused a problem, previous episodes of pain that were investigated and attributed to the gallbladder, and any family history of gallbladder disease if your prescriber asks. The more complete the picture, the better the clinical decision.

If you've already started Wegovy (or semaglutide in any form) and you develop new abdominal symptoms, contact your prescriber before your next scheduled review rather than waiting. Dose escalation can increase GI effects generally, and it's worth the prescriber knowing whether any new symptoms are settling GI side effects or something that warrants investigation.

Our detailed eligibility page on this topic sets out what the prescribing criteria look like in practice. If you have questions that aren't answered there, our clinical team is accessible seven days a week. To discuss your specific history with a prescriber, you can start your free consultation, a real clinician reviews it the same day, not an algorithm.